Jung-Hyun Kim

7PUBLICATIONS
18CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsDevelopmental genetics (incl. sex determination)MechanobiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies.

Sanga Choi, Jieun Kang, Jung-Hyun Kim

|Sep 23, 2024
SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer.

Joshua B Phillips, Seong-Sik Park, Cheng-Han Lin

|Sep 15, 2021
Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON.

Alexander J M Dingemans, Kim M G Truijen, Jung-Hyun Kim

|Jun 07, 2019
Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells.

Joshua K Stone, Jung-Hyun Kim, Lana Vukadin

|May 22, 2019
FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation.

James M Murphy, Kyuho Jeong, Yelitza A R Rodriguez

Pageof 2